Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

DBT Inhibitors

DBT inhibitors encompass a diverse range of compounds primarily characterized by their ability to modulate the function of the Doubletime (DBT) protein. DBT, known for its significant role in the regulation of circadian rhythms, operates predominantly through kinase activities, making kinase inhibition a primary method of its modulation. Compounds such as Staurosporine and Bisindolylmaleimide I exemplify this approach by directly targeting the kinase activity of DBT, thereby influencing its regulatory functions.

Apart from direct kinase inhibition, DBT inhibitors also include compounds that indirectly affect DBT's role in various signaling pathways. This indirect inhibition is crucial because DBT does not operate in isolation but is part of larger cellular signaling networks. Compounds like H-89 and U0126, which inhibit protein kinase A and MEK respectively, demonstrate this method. By targeting these enzymes, these inhibitors can modulate the phosphorylation cascade that DBT is a part of, thus influencing its activity. Similarly, PI3K inhibitors such as LY 294002 and Wortmannin, and the mTOR inhibitor Rapamycin, demonstrate how the inhibition of other components in the signaling pathways can indirectly impact DBT's function.

In addition to these, inhibitors targeting other kinases like p38 MAP kinase (SB 203580), JNK (SP600125), c-Raf (ZM 336372), and ERK (SL-327) also form part of this chemical class. These compounds, though not directly interacting with DBT, have the potential to modulate its activity by altering the signaling landscape within which DBT operates. The diversity of these inhibitors, ranging from broad-spectrum kinase inhibitors to more targeted compounds, highlights the complexity of the signaling pathways DBT is involved in and the various points at which these pathways can be modulated to influence DBT's activity. Overall, through both direct kinase inhibition and indirect modulation of related signaling pathways, these compounds exhibit the potential to influence DBT's function in significant ways.

SEE ALSO...

Items 31 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING